Literature DB >> 31537755

Adipogenic progenitors keep muscle stem cells young.

Sara Ancel1,2, Omid Mashinchian1,2, Jerome N Feige1,2.   

Abstract

Entities:  

Keywords:  aging; fibro/adipogenic progenitor; muscle stem cell; niche; regeneration

Year:  2019        PMID: 31537755      PMCID: PMC6782005          DOI: 10.18632/aging.102304

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


× No keyword cloud information.
Declining stem cell function during aging leads to impaired tissue function and contributes to delayed tissue repair following damage. In adult skeletal muscle, loss of myofiber integrity caused by mechanical injuries or diseases are repaired by resident muscle stem cells (MuSCs), called satellite cells, which promptly exit from quiescence after disruption of muscle architecture to expand, differentiate and drive tissue regeneration. The fate of MuSCs fundamentally depends on the “niche”, their local environment, which is orchestrated by diverse cellular and acellular elements. Aging causes cell-extrinsic changes to the MuSC niche and dysregulates signaling pathways, which collectively alter the regenerative function of MuSCs [1]. The low regenerative capacity of aged muscle also contributes to the development of fibrosis in response to aberrant systemic cues. Fibro/adipogenic progenitors (FAPs) constitute a population of interstitial mesenchymal cells in skeletal muscle which are devoid of myogenic potential, but support muscle stem cell commitment and can differentiate to the adipogenic or fibrotic lineages (Figure 1A) [2]. A “regenerative” population of FAPs expands in response to injury to supply transient support-signals and regulate the commitment of MuSCs during muscle regeneration [3,4]. Genetic muscle diseases such as Duchenne muscular dystrophy generate “pathological” FAPs, and cause dysbiosis between FAPs and MuSCs, impaired regenerative capacity and muscle infiltration of adipose tissue and fibrosis [4]. However, much less is known on the chronic contribution of FAPs to muscle homeostasis and on the influence of aging on the cross-talk between FAPs and MuSCs.
Figure 1

Fibro-adipogenic progenitors (FAPs) dynamically cross-talk with the muscle stem cell (MuSC) niche to regulate regeneration and ECM/lipid turnover in different patho-physiologcal cues. (A) FAPs have distinct cellular fates and functions in different patho-physiological conditions; support to muscle fibers in homeostatic conditions [5]; support to muscle stem cells during regeneration [2]; pathological differentiation to fat and fibrosis [4,6]. (B) Aging alters the support of FAPs to MuSCs and regeneration and promotes their pathological skewing to fibrosis over adipogenesis [6].

Fibro-adipogenic progenitors (FAPs) dynamically cross-talk with the muscle stem cell (MuSC) niche to regulate regeneration and ECM/lipid turnover in different patho-physiologcal cues. (A) FAPs have distinct cellular fates and functions in different patho-physiological conditions; support to muscle fibers in homeostatic conditions [5]; support to muscle stem cells during regeneration [2]; pathological differentiation to fat and fibrosis [4,6]. (B) Aging alters the support of FAPs to MuSCs and regeneration and promotes their pathological skewing to fibrosis over adipogenesis [6]. A recent study from the Rando laboratory demonstrated an important function of FAPs in maintaining long-term homeostasis of skeletal muscle [5]. Long term in-vivo depletion of “homeostatic” FAPs using PDGFRα-Cre mediated ablation decreased the number of MuSCs and reduced muscle mass and strength, suggesting a critical role of FAPs in maintaining the stem cell pool and sustaining myofiber growth and turnover. In a more acute setting, the absence of regenerative FAP amplification during regeneration following muscle injury also blocked MuSC expansion and delayed regeneration of damaged myofibers. Interestingly, FAP depletion also impaired expansion of CD45+ hematopoietic cells at the site of injury [5]. Thus, FAPs are active regulators of cellular communication in skeletal muscle niche where they directly control tissue homeostasis and regeneration by supporting MuSCs and myofibers. The decline of MuSC function and muscle regenerative capacity during aging is under the control of a wide range of signals, out of which many arise from extrinsic cues coming from the local or systemic environment [1]. In a recent study, our lab investigated how aging influences the fate of FAPs and their cross-talk with MuSCs to regulate the balance between myogenesis, adipogenesis and fibrosis in skeletal muscle ([6]; Figure 1B). Aging causes a clonal selection of FAPs, which favors their fibrogenic over adipogenic conversion. Interestingly, aged FAPs fail to efficiently amplify following muscle injury and aging alters the capacity of FAPs to support MuSC amplification and commitment. Both in-vitro co-culture and in-vivo transplantation of young FAPs rejuvenate aged MuSC function, but aged FAPs lose the ability to efficiently support MuSCs. The fact that the support of FAPs to MuSCs is communicable via conditioned medium suggested that soluble factors regulate this paracrine cross-talk. Using transcriptomic profiling followed by in-vitro and in-vivo validation, we could identify that altered secretion of the FAP-secreted matricellular protein WISP-1 (WNT1 Inducible Signaling Pathway Protein 1, also called CCN-4) drives the perturbed support of aged FAPs to MuSCs. Genetic invalidation of WISP1 disrupts the communication between FAPs and MuSCs and leads to abnormal regeneration of skeletal muscle. Mechanistically, WISP-1 controls MuSC asymmetric expansion by activating Akt signaling. Importantly, this new paracrine mechanism can be targeted therapeutically by administering recombinant WISP-1 systemically. Altogether, our work reveals that loss of WISP1 from FAPs directly contributes to MuSC dysfunction in aged muscle and demonstrates that adipogenic progenitors are not just quiescent precursors waiting for pathological cues to elicit pathological conversions, but actually constitute bona fide elements of the stem cell niche, which regulate an active cross-talk with stem cells via paracrine signaling [6]. Along similar lines, a subpopulation of stromal progenitors in adipose tissue has recently been identified using single-cell RNA sequencing as a negative regulator of adipogenesis which represses the differentiation of adipocytes and keeps fat expansion in check [7]. FAPs are also likely a heterogeneous population and the clonal selection of different fates of FAPs during aging suggests a differential effect of age on distinct subpopulations. A recent study by Malecova et al. [8] reports a dynamic specialization of sub-FAPs in physiological and diseased conditions. While Tie2-expressing FAPs predominantly reside within neonatal and adult homeostatic muscles, another injury-activated subpopulation of FAPs characterized by Vcam1 expression is associated with regeneration of injured myofibers [8]. Future research will be necessary to further dissect FAP function during homeostasis and tissue repair and unravel how the heterogeneity of this population is orchestrated in health and disease. In particular, the signals that mediate FAP dysfunction and the spatio-temporal control of their fate and interactions with MuSCs will be key to understand how aging of different compartments of the stem cell niche contribute to global regenerative capacity.
  8 in total

1.  Mesenchymal Stromal Cells Are Required for Regeneration and Homeostatic Maintenance of Skeletal Muscle.

Authors:  Michael N Wosczyna; Colin T Konishi; Edgar E Perez Carbajal; Theodore T Wang; Rachel A Walsh; Qiang Gan; Mark W Wagner; Thomas A Rando
Journal:  Cell Rep       Date:  2019-05-14       Impact factor: 9.423

2.  A stromal cell population that inhibits adipogenesis in mammalian fat depots.

Authors:  Petra C Schwalie; Hua Dong; Magda Zachara; Julie Russeil; Daniel Alpern; Nassila Akchiche; Christian Caprara; Wenfei Sun; Kai-Uwe Schlaudraff; Gianni Soldati; Christian Wolfrum; Bart Deplancke
Journal:  Nature       Date:  2018-06-20       Impact factor: 49.962

3.  Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis.

Authors:  Aaron W B Joe; Lin Yi; Anuradha Natarajan; Fabien Le Grand; Leslie So; Joy Wang; Michael A Rudnicki; Fabio M V Rossi
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

4.  Aging Disrupts Muscle Stem Cell Function by Impairing Matricellular WISP1 Secretion from Fibro-Adipogenic Progenitors.

Authors:  Laura Lukjanenko; Sonia Karaz; Pascal Stuelsatz; Uxia Gurriaran-Rodriguez; Joris Michaud; Gabriele Dammone; Federico Sizzano; Omid Mashinchian; Sara Ancel; Eugenia Migliavacca; Sophie Liot; Guillaume Jacot; Sylviane Metairon; Frederic Raymond; Patrick Descombes; Alessio Palini; Benedicte Chazaud; Michael A Rudnicki; C Florian Bentzinger; Jerome N Feige
Journal:  Cell Stem Cell       Date:  2019-01-24       Impact factor: 24.633

Review 5.  The central role of muscle stem cells in regenerative failure with aging.

Authors:  Helen M Blau; Benjamin D Cosgrove; Andrew T V Ho
Journal:  Nat Med       Date:  2015-08       Impact factor: 53.440

Review 6.  A Muscle Stem Cell Support Group: Coordinated Cellular Responses in Muscle Regeneration.

Authors:  Michael N Wosczyna; Thomas A Rando
Journal:  Dev Cell       Date:  2018-07-16       Impact factor: 12.270

7.  Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors.

Authors:  Dario R Lemos; Farshad Babaeijandaghi; Marcela Low; Chih-Kai Chang; Sunny T Lee; Daniela Fiore; Regan-Heng Zhang; Anuradha Natarajan; Sergei A Nedospasov; Fabio M V Rossi
Journal:  Nat Med       Date:  2015-06-08       Impact factor: 53.440

8.  Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy.

Authors:  Barbora Malecova; Sole Gatto; Usue Etxaniz; Magda Passafaro; Amy Cortez; Chiara Nicoletti; Lorenzo Giordani; Alessio Torcinaro; Marco De Bardi; Silvio Bicciato; Francesca De Santa; Luca Madaro; Pier Lorenzo Puri
Journal:  Nat Commun       Date:  2018-09-10       Impact factor: 14.919

  8 in total
  5 in total

1.  High-resolution genome-wide expression analysis of single myofibers using SMART-Seq.

Authors:  Darren M Blackburn; Felicia Lazure; Aldo H Corchado; Theodore J Perkins; Hamed S Najafabadi; Vahab D Soleimani
Journal:  J Biol Chem       Date:  2019-11-21       Impact factor: 5.157

Review 2.  Role of fibro-adipogenic progenitor cells in muscle atrophy and musculoskeletal diseases.

Authors:  Emily Parker; Mark W Hamrick
Journal:  Curr Opin Pharmacol       Date:  2021-04-08       Impact factor: 4.768

3.  Latest advances in aging research and drug discovery.

Authors:  Daniela Bakula; Andrea Ablasser; Adriano Aguzzi; Adam Antebi; Nir Barzilai; Martin-Immanuel Bittner; Martin Borch Jensen; Cornelis F Calkhoven; Danica Chen; Aubrey D N J de Grey; Jerome N Feige; Anastasia Georgievskaya; Vadim N Gladyshev; Tyler Golato; Andrei V Gudkov; Thorsten Hoppe; Matt Kaeberlein; Pekka Katajisto; Brian K Kennedy; Unmesh Lal; Ana Martin-Villalba; Alexey A Moskalev; Ivan Ozerov; Michael A Petr; David C Rubinsztein; Alexander Tyshkovskiy; Quentin Vanhaelen; Alex Zhavoronkov; Morten Scheibye-Knudsen
Journal:  Aging (Albany NY)       Date:  2019-11-21       Impact factor: 5.682

4.  The role of the aging microenvironment on the fate of PDGFRβ lineage cells in skeletal muscle repair.

Authors:  Aiping Lu; Chieh Tseng; Ping Guo; Zhanguo Gao; Kaitlyn E Whitney; Mikhail G Kolonin; Johnny Huard
Journal:  Stem Cell Res Ther       Date:  2022-08-05       Impact factor: 8.079

5.  Single-cell dissection of the obesity-exercise axis in adipose-muscle tissues implies a critical role for mesenchymal stem cells.

Authors:  Jiekun Yang; Maria Vamvini; Pasquale Nigro; Li-Lun Ho; Kyriakitsa Galani; Marcus Alvarez; Yosuke Tanigawa; Ashley Renfro; Nicholas P Carbone; Markku Laakso; Leandro Z Agudelo; Päivi Pajukanta; Michael F Hirshman; Roeland J W Middelbeek; Kevin Grove; Laurie J Goodyear; Manolis Kellis
Journal:  Cell Metab       Date:  2022-10-04       Impact factor: 31.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.